Aileron Therapeutics Inc ALRN

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

9d ago, source:

Topline results from Phase 1b study of LTI-03, a novel Caveolin-1-related peptide in development for the treatment of ...

Aileron Therapeutics Inc (ALRN) Stock: Navigating the Market Volatility

7d ago, source: newsheater

The stock of Aileron Therapeutics Inc (ALRN) has seen a -9.17% decrease in the past week, with a -4.12% drop in the past month, and a 19.15% flourish in the past quarter. The volatility ratio for the ...

Aileron Therapeutics Stock (NASDAQ:ALRN), Quotes and News Summary

27d ago, source: Benzinga.com

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after ...

Aileron Therapeutics gets grant for modified CAV-1 peptides for lung infection and injury treatment

9d ago, source: Pharmaceutical Technology

Discover the groundbreaking patent by Aileron Therapeutics for modified caveolin-1 peptides to treat lung infections and fibrosis. Learn about the unique peptide sequence and its potential ...

Aileron Therapeutics sharestarget doubled by Ladenburg Thalmann

6d ago, source: Investing

On Thursday, Ladenburg Thalmann demonstrated confidence in Aileron Therapeutics Inc (NASDAQ:ALRN) shares, with a significant increase in the company's stock price target. The firm doubled the ...

Aileron Therapeutics, Inc.

3y ago, source: CNN

Aileron Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and ...

Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

9d ago, source: Stockhouse

CloseCurlyDoubleQuote; In October 2023, Aileron acquired Lung Therapeutics, Inc. (“Lung”), shifting the Company’s disease focus to advance a pipeline of ...

Aileron Therapeutics, Inc.: Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

8d ago, source:

Topline results from Phase 1b study of LTI-03, a novel Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis, expected to be reported in the third quarter of 202 ...

Aileron Therapeutics Inc ALRN

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aileron Therapeutics Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...